Add to Watchlist
View Current for NVS
View SuperFeed for NVS
View Charts for NVS
Add or remove $NVS from your watchlists:
Hang tight! We're updating your watchlist data. This might take a minute...
Done
Manage Watchlists
Novartis AG ADR
Health Care
Novartis AG researches, develops, manufactures, and markets healthcare products in Switzerland and internationally. The company operates through two …
more
Conversation Volume
Last 60 days
There is not enough conversation volume about this stock
Key Opinion Leaders
Strongest 30-day focus on $NVS by total mentions
Real-time Chart
Price Chart for $NVS
Conviction History
Bullish vs Bearish Conviction over the last 30 days.
This color denotes Market Hours (US/Eastern)
There is not enough conversation volume about this stock
Thread Explorer
Explore popular threads around $NVS
There are no threads for this stock
Chart Explorer
Explore recent charts, graphs, and media
There are no charts for this stock
Rarely do we see this kind of divergence between value ($SPYV = black line) and growth ($SPYG = red line). Check it out this 5 year chart...
Go to Chart Explorer
Latest News
Get the latest breaking news from the community
There is no recent news for this stock
Loading news, hang tight...
Google Search Trends - Past 12 months
Instantly visualize search trends for this specific symbol
Today
Past 7 days
Past 30 days
Past 60 days
Custom
Company Profile
Novartis AG researches, develops, manufactures, and markets healthcare products in Switzerland and internationally. The company operates through two segments: Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and physicians. It also provides cardiovascular, ophthalmology, neuroscience, immunology, hematology, and solid tumor products. The Sandoz segment develops, manufactures, and markets finished dosage forms of small molecule pharmaceuticals to third parties. It also provides protein- or other biotechnology-based products, including biosimilars; and biotechnology manufacturing services; and anti-infectives, such as active pharmaceutical ingredients and intermediates primarily antibiotics. Novartis AG has a license and collaboration agreement with Alnylam Pharmaceuticals to develop, manufacture, and commercialize inclisiran, a therapy to reduce LDL cholesterol. Novartis AG was incorporated in 1996 and is headquartered in Basel, Switzerland.
Market Cap Type: Large
Close
Date,Time,Temperature
2024-04-10,16,0
2024-04-10,17,0
2024-04-10,18,0
2024-04-10,19,0
2024-04-10,20,0
2024-04-10,21,0
2024-04-10,22,0
2024-04-10,23,0
2024-04-11,0,0
2024-04-11,1,0
2024-04-11,2,0
2024-04-11,3,0
2024-04-11,4,0
2024-04-11,5,0
2024-04-11,6,0
2024-04-11,7,0
2024-04-11,8,0
2024-04-11,9,0
2024-04-11,10,0
2024-04-11,11,0
2024-04-11,12,0
2024-04-11,13,0
2024-04-11,14,0
2024-04-11,15,0
2024-04-11,16,0
2024-04-11,17,0
2024-04-11,18,0
2024-04-11,19,0
2024-04-11,20,0
2024-04-11,21,0
2024-04-11,22,0
2024-04-11,23,0
2024-04-12,0,0
2024-04-12,1,0
2024-04-12,2,0
2024-04-12,3,0
2024-04-12,4,0
2024-04-12,5,0
2024-04-12,6,0
2024-04-12,7,0
2024-04-12,8,0
2024-04-12,9,0
2024-04-12,10,0
2024-04-12,11,0
2024-04-12,12,0
2024-04-12,13,0
2024-04-12,14,0
2024-04-12,15,0
2024-04-12,16,0
2024-04-12,17,0
2024-04-12,18,0
2024-04-12,19,0
2024-04-12,20,0
2024-04-12,21,0
2024-04-12,22,0
2024-04-12,23,0
2024-04-13,0,0
2024-04-13,1,0
2024-04-13,2,0
2024-04-13,3,0
2024-04-13,4,0
2024-04-13,5,0
2024-04-13,6,0
2024-04-13,7,0
2024-04-13,8,0
2024-04-13,9,0
2024-04-13,10,0
2024-04-13,11,0
2024-04-13,12,0
2024-04-13,13,0
2024-04-13,14,0
2024-04-13,15,0
2024-04-13,16,0
2024-04-13,17,0
2024-04-13,18,0
2024-04-13,19,0
2024-04-13,20,0
2024-04-13,21,0
2024-04-13,22,0
2024-04-13,23,0
2024-04-14,0,0
2024-04-14,1,0
2024-04-14,2,0
2024-04-14,3,0
2024-04-14,4,0
2024-04-14,5,0
2024-04-14,6,0
2024-04-14,7,0
2024-04-14,8,0
2024-04-14,9,0
2024-04-14,10,0
2024-04-14,11,0
2024-04-14,12,0
2024-04-14,13,0
2024-04-14,14,0
2024-04-14,15,0
2024-04-14,16,0
2024-04-14,17,0
2024-04-14,18,0
2024-04-14,19,0
2024-04-14,20,0
2024-04-14,21,0
2024-04-14,22,0
2024-04-14,23,0
2024-04-15,0,0
2024-04-15,1,0
2024-04-15,2,0
2024-04-15,3,0
2024-04-15,4,0
2024-04-15,5,0
2024-04-15,6,0
2024-04-15,7,0
2024-04-15,8,0
2024-04-15,9,0
2024-04-15,10,0
2024-04-15,11,0
2024-04-15,12,0
2024-04-15,13,0
2024-04-15,14,0
2024-04-15,15,0
2024-04-15,16,0
2024-04-15,17,0
2024-04-15,18,0
2024-04-15,19,0
2024-04-15,20,0
2024-04-15,21,0
2024-04-15,22,0
2024-04-15,23,0
2024-04-16,0,0
2024-04-16,1,0
2024-04-16,2,0
2024-04-16,3,0
2024-04-16,4,0
2024-04-16,5,0
2024-04-16,6,0
2024-04-16,7,0
2024-04-16,8,0
2024-04-16,9,0
2024-04-16,10,0
2024-04-16,11,0
2024-04-16,12,0
2024-04-16,13,0
2024-04-16,14,0
2024-04-16,15,0
2024-04-16,16,0
2024-04-16,17,0
2024-04-16,18,0
2024-04-16,19,0
2024-04-16,20,0
2024-04-16,21,0
2024-04-16,22,0
2024-04-16,23,0
2024-04-17,0,0
2024-04-17,1,0
2024-04-17,2,0
2024-04-17,3,0
2024-04-17,4,0
2024-04-17,5,0
2024-04-17,6,0
2024-04-17,7,0
2024-04-17,8,0
2024-04-17,9,0
2024-04-17,10,0
2024-04-17,11,0
2024-04-17,12,0
2024-04-17,13,0
2024-04-17,14,0
2024-04-17,15,0
2024-04-17,16,0
2024-04-17,17,0
2024-04-17,18,0
2024-04-17,19,0
2024-04-17,20,0
2024-04-17,21,0
2024-04-17,22,0
2024-04-17,23,0
2024-04-18,0,0
2024-04-18,1,0
2024-04-18,2,0
2024-04-18,3,0
2024-04-18,4,0
2024-04-18,5,0
2024-04-18,6,0
2024-04-18,7,0
2024-04-18,8,0
2024-04-18,9,0
2024-04-18,10,0
2024-04-18,11,0
2024-04-18,12,0
2024-04-18,13,0
2024-04-18,14,0
2024-04-18,15,0
2024-04-18,16,0
2024-04-18,17,0
2024-04-18,18,0
2024-04-18,19,0
2024-04-18,20,0
2024-04-18,21,0
2024-04-18,22,0
2024-04-18,23,0
2024-04-19,0,0
2024-04-19,1,0
2024-04-19,2,0
2024-04-19,3,0
2024-04-19,4,0
2024-04-19,5,0
2024-04-19,6,0
2024-04-19,7,0
2024-04-19,8,0
2024-04-19,9,0
2024-04-19,10,0
2024-04-19,11,0
2024-04-19,12,0
2024-04-19,13,0
2024-04-19,14,0
2024-04-19,15,0
2024-04-19,16,0
2024-04-19,17,0
2024-04-19,18,0
2024-04-19,19,0
2024-04-19,20,0
2024-04-19,21,0
2024-04-19,22,0
2024-04-19,23,0
2024-04-20,0,0
2024-04-20,1,0
2024-04-20,2,0
2024-04-20,3,0
2024-04-20,4,0
2024-04-20,5,0
2024-04-20,6,0
2024-04-20,7,0
2024-04-20,8,0
2024-04-20,9,0
2024-04-20,10,0
2024-04-20,11,0
2024-04-20,12,0
2024-04-20,13,0
2024-04-20,14,0
2024-04-20,15,0
2024-04-20,16,0
2024-04-20,17,0
2024-04-20,18,0
2024-04-20,19,0
2024-04-20,20,0
2024-04-20,21,0
2024-04-20,22,0
2024-04-20,23,0
2024-04-21,0,0
2024-04-21,1,0
2024-04-21,2,0
2024-04-21,3,0
2024-04-21,4,0
2024-04-21,5,0
2024-04-21,6,0
2024-04-21,7,0
2024-04-21,8,0
2024-04-21,9,0
2024-04-21,10,0
2024-04-21,11,0
2024-04-21,12,0
2024-04-21,13,0
2024-04-21,14,0
2024-04-21,15,0
2024-04-21,16,0
2024-04-21,17,0
2024-04-21,18,0
2024-04-21,19,0
2024-04-21,20,0
2024-04-21,21,0
2024-04-21,22,0
2024-04-21,23,0
2024-04-22,0,0
2024-04-22,1,0
2024-04-22,2,0
2024-04-22,3,0
2024-04-22,4,0
2024-04-22,5,0
2024-04-22,6,0
2024-04-22,7,0
2024-04-22,8,0
2024-04-22,9,0
2024-04-22,10,0
2024-04-22,11,0
2024-04-22,12,0
2024-04-22,13,0
2024-04-22,14,0
2024-04-22,15,0
2024-04-22,16,0
2024-04-22,17,0
2024-04-22,18,0
2024-04-22,19,0
2024-04-22,20,0
2024-04-22,21,0
2024-04-22,22,0
2024-04-22,23,0
2024-04-23,0,0
2024-04-23,1,0
2024-04-23,2,0
2024-04-23,3,0
2024-04-23,4,0
2024-04-23,5,0
2024-04-23,6,0
2024-04-23,7,0
2024-04-23,8,0
2024-04-23,9,0
2024-04-23,10,0
2024-04-23,11,0
2024-04-23,12,0
2024-04-23,13,0
2024-04-23,14,0
2024-04-23,15,0
2024-04-23,16,0
2024-04-23,17,0
2024-04-23,18,0
2024-04-23,19,0
2024-04-23,20,0
2024-04-23,21,0
2024-04-23,22,0
2024-04-23,23,0
2024-04-24,0,0
2024-04-24,1,0
2024-04-24,2,0
2024-04-24,3,0
2024-04-24,4,0
2024-04-24,5,0
2024-04-24,6,0
2024-04-24,7,0
2024-04-24,8,0
2024-04-24,9,0.495449997484684